Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy

• Status: Completed
• Trial end date: 2013-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the adherence to an enhanced recovery after surgery (ERAS) pathway and the impact of the ERAS protocol on postoperative short-term outcome in patients undergoing pancreaticoduodenectomy (PD).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Università Vita-Salute San Raffaele
• Collaborator: Ospedale San Raffaele
• Treatments: Anesthetics; BB 1101; Dexamethasone; Dexamethasone 21-phosphate; Dexamethasone acetate; Diazepam; Ondansetron; Ropivacaine; Sufentanil

Criteria

Inclusion Criteria:

• All patients undergoing elective pancreaticoduodenectomy

Exclusion Criteria:

• Intraoperative detection of metastatic disease (non-operability)